The company's stock now has 30.68 Million in market capitalization. It opened the session with a $0.1803 price tag, later ranging from $0.167 to $0.1803, the range at which the stock has traded at throughout the day. (NASDAQ:IMNP) has 170.43 million outstanding shares among them 166.40 million shares have been floated in market exchange. (NASDAQ:IMNP) by some 2,397,266 shares, 6 decreased positions by 408,628 and 2 held positions by 2,198,395.
Price Target is an important factor while doing analysis of a stock.
Amid volatile financial markets and the presidential election, various investment brokerages have made amendments to their price targets and ratings on shares of Immune Pharmaceuticals Inc (IMNP).
Not many analysts have released their opinion on Immune Pharmaceuticals, Inc.
For the quarter ending 08/15/2016, The Analyst projected that the company could deliver EPS of -0.13 while the company provided its Actual EPS of -0.13 showing a difference of 0 Percent between the Estimated and Actual EPS.
Immune Pharmaceuticals Ltd.is a biopharmaceutical company which is engaged in the development of monoclonal antibodies for the treatment of inflammatory diseases and cancer.
When calculating EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at 38.20%. Immune Pharmaceuticals, Inc. got Initiated on 8-Oct-15 where investment firm ROTH Capital Initiated the stock to Buy. Current price places the company's stock -39.85% away from its 200-day simple moving average, -10.59%, away from the 50-day average and also -9.26% away from 20-day average. The last session's volume of 2.44 million shares was higher than its average volume of 1.78 million shares. The stock's market capitalization is 23.63M, it has a 52-week low of 0.16 and a 52-week high of 0.64. The company reached a 52-week low at 0.16 on Dec 1, 2016. The stock's quarterly performance indicates a Negative momentum of -5.26 percent, whereas its last one month trend is Pessimistic with -14.61 percent.
The stock was able to keep return on assets at 1.76% in the trailing twelve month while Reuters data showed that industry's average stands at 1.68% and sector's optimum level is 2.41%. The monthly stock performance comes in at 4.86%.
The Relative Volume of the company is 0.95 and Average Volume (3 months) is 5.96 million. Weekly performance analysis shows the equity at 0.96%.
The stock now has its Annual Dividend of $0 and an annual Dividend Yield of 0 Percent. IMNP has P/E (Price to Earnings ttm) value of 0, Forward P/E of 1.06, P/C (Price to cash per share) of 102.26 and Price to Free Cash Flow (P/FCF) value of 0.